These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10819459)

  • 21. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
    Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
    J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet 5-HT transport in depressed patients under double-blind treatment with paroxetine versus amitriptyline.
    Schlake HP; Kuhs H; Rolf LH; Bosse T; Schuhknecht E; Rudolf GA; Brune GG
    Acta Psychiatr Scand Suppl; 1989; 350():149-51. PubMed ID: 2530775
    [No Abstract]   [Full Text] [Related]  

  • 23. Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy.
    Diler RS; Tamam L; Avci A
    J Clin Psychopharmacol; 2000 Oct; 20(5):586-7. PubMed ID: 11001250
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic.
    Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E
    Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Is there a new trend in antidepressive therapy? Bonn, 2 July 1993].
    Nervenarzt; 1993 Oct; 64(10 Suppl):1-8. PubMed ID: 7477595
    [No Abstract]   [Full Text] [Related]  

  • 26. Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy.
    Dunbar GC
    Pharmacology; 1995 Sep; 51(3):137-44. PubMed ID: 7501698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The paroxetine controversy: lessons for ketamine trials.
    Zhang MW; Ho RC
    Lancet Psychiatry; 2015 Dec; 2(12):1057-8. PubMed ID: 26613847
    [No Abstract]   [Full Text] [Related]  

  • 28. Paroxetine-induced bruxism effectively treated with tandospirone.
    Kishi Y
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):90-1. PubMed ID: 17308240
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L; Septien L; Azoulay P
    CNS Drugs; 2002; 16(1):65-75. PubMed ID: 11772119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paroxetine-Overview of the Molecular Mechanisms of Action.
    Kowalska M; Nowaczyk J; Fijałkowski Ł; Nowaczyk A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Akathisia: a review and case report following paroxetine treatment.
    Baldassano CF; Truman CJ; Nierenberg A; Ghaemi SN; Sachs GS
    Compr Psychiatry; 1996; 37(2):122-4. PubMed ID: 8654061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.
    Van Holten TC; Roest M; Riphagen J; Jansen C; Naarding P; Adriaansen HJ; De Groot PG; Remijn JA
    J Thromb Haemost; 2012 Jun; 10(6):1177-9. PubMed ID: 22429872
    [No Abstract]   [Full Text] [Related]  

  • 33. Lower gastrointestinal bleeding and paroxetine use: two case reports.
    Blasco-Fontecilla H; de Leon J
    Psychosomatics; 2012; 53(2):184-7. PubMed ID: 22424167
    [No Abstract]   [Full Text] [Related]  

  • 34. Paroxetine treatment of major depressive disorder.
    Keller MB
    Psychopharmacol Bull; 2003; 37 Suppl 1():42-52. PubMed ID: 14566200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adverse effects after switching to a different generic form of paroxetine: paroxetine mesylate instead of paroxetine HCl hemihydrate].
    Vergouwen AC; Bakker A
    Ned Tijdschr Geneeskd; 2002 Apr; 146(17):811-2. PubMed ID: 12014241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hold on tight.
    Grochowik AM
    Psychiatr Serv; 2006 Dec; 57(12):1705-7. PubMed ID: 17158482
    [No Abstract]   [Full Text] [Related]  

  • 38. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is GSK guilty of fraud?
    Lancet
    Lancet; 2004 Jun; 363(9425):1919. PubMed ID: 15194246
    [No Abstract]   [Full Text] [Related]  

  • 40. Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent.
    Campo JV; Smith C; Perel JM
    Arch Gen Psychiatry; 1998 Nov; 55(11):1050-2. PubMed ID: 9819077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.